(TSX:CNE),(OTC US:CNNEF),(Other OTC:CNNEF),(BVC:CNEC),(BVC:CNEC.CL), CALGARY, Alberta, Jan. 07, 2026 (GLOBE NEWSWIRE) — (“Canacol” or the “Company”) refers to its prior announcement regarding the Company's agreement for debtor-in-possession financing and related documentation (the “DIP Financing”). In that announcement, the Company disclosed entry into a commitment letter governing the DIP Financing (collectively, the “DIP Commitment Letter”) with an […]

OBOOK Holdings Inc. (OWLS) to Adopt x402 Standard to Unlock AI Agent Revenue for Global Merchants Leveraging its global regulatory footprint, OwlTing aims to provide merchants the ability to accept payments from the next generation of AI buyers GlobeNewswire January 08, 2026 ARLINGTON, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) — OBOOK Holdings Inc. (NASDAQ: OWLS)

Canacol Energy Closes Initial Advance Under DIP Financing GlobeNewswire January 08, 2026 CALGARY, Alberta, Jan. 07, 2026 (GLOBE NEWSWIRE) — (“Canacol” or the “Company”) refers to its prior announcement regarding the Company's agreement for debtor-in-possession financing and related documentation (the “DIP Financing”). In that announcement, the Company disclosed entry into a commitment letter governing the

(NASDAQ:PHAT), FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public offering of 6,875,000 shares of its common stock and pre-funded warrants to purchase 1,250,078 shares of common stock.

(NASDAQ:FFIV), NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company's securities between October 28, 2024, and

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire January 08, 2026 FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the pricing of an underwritten public

F5 Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against F5, Inc. – FFIV GlobeNewswire January 08, 2026 NEW ORLEANS, La., Jan. 07, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file

(NYSE:ARE), NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE), if they purchased or otherwise acquired the Company's

Alexandria Real Estate Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Alexandria Real Estate Equities, Inc. – ARE GlobeNewswire January 08, 2026 NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January

(NYSE:KLAR), NEW ORLEANS, Jan. 07, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company's securities pursuant and/or traceable to the registration statement and